| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Oncotelic Therapeutics Inc (OTCQB: OTLC)
OTLC Technical Analysis
5
| As on 9th Jun 2023 OTLC SHARE Price closed @ 0.03 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.15 & Strong Sell for SHORT-TERM with Stoploss of 0.18 we also expect STOCK to react on Following IMPORTANT LEVELS. |
OTLCSHARE Price
| Open | 0.03 | Change | Price | % |
| High | 0.03 | 1 Day | 0.00 | 0.00 |
| Low | 0.03 | 1 Week | 0.00 | 0.00 |
| Close | 0.03 | 1 Month | -0.01 | -25.00 |
| Volume | 74196 | 1 Year | -0.14 | -82.35 |
| 52 Week High 0.25 | 52 Week Low 0.03 | ||||
OTCQB USA Most Active Stocks
| BMIX | 0.01 | % |
| MOBQ | 0.18 | -5.26% |
| FNMA | 0.45 | 0.00% |
| ALPP | 3.56 | -0.80% |
| ALPP | 3.56 | -0.80% |
| SHMP | 0.06 | 0.00% |
| NWBO | 0.73 | 0.00% |
| VPLM | 0.08 | % |
| NLST | 3.72 | -8.60% |
| SRNA | 2.78 | 14.88% |
OTCQB USA Top Gainers Stocks
OTCQB USA Top Losers Stocks
| OTLC Daily Charts |
OTLC Intraday Charts |
Whats New @ Bazaartrend |
OTLC Free Analysis |
|
|
OTLC Important Levels Intraday
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
OTLC Forecast April 2024
| 4th UP Forecast | 0.15 |
| 3rd UP Forecast | 0.11 |
| 2nd UP Forecast | 0.09 |
| 1st UP Forecast | 0.06 |
| 1st DOWN Forecast | 0 |
| 2nd DOWN Forecast | -0.03 |
| 3rd DOWN Forecast | -0.05 |
| 4th DOWN Forecast | -0.09 |
OTLC Weekly Forecast
| 4th UP Forecast | 0.11 |
| 3rd UP Forecast | 0.08 |
| 2nd UP Forecast | 0.07 |
| 1st UP Forecast | 0.05 |
| 1st DOWN Forecast | 0.01 |
| 2nd DOWN Forecast | -0.01 |
| 3rd DOWN Forecast | -0.02 |
| 4th DOWN Forecast | -0.05 |
OTLC Forecast2024
| 4th UP Forecast | 0.49 |
| 3rd UP Forecast | 0.34 |
| 2nd UP Forecast | 0.25 |
| 1st UP Forecast | 0.16 |
| 1st DOWN Forecast | -0.1 |
| 2nd DOWN Forecast | -0.19 |
| 3rd DOWN Forecast | -0.28 |
| 4th DOWN Forecast | -0.43 |
Oncotelic Therapeutics Inc ( OTCQB USA Symbol : OTLC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
OTLC Business Profile
Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. The company's lead product candidate is OT-101, an antisense against TGF-beta, which is in phase 3 clinical trials for pancreatic cancer and glioblastoma, as well as develops OT-101 for the treatment of various viruses, including severe acute respiratory syndrome and coronavirus. It also develops OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes; and CA4P for the treatment of advanced metastatic melanoma. The company is headquartered in Agoura Hills, California. Address: 29397 Agoura Road, Agoura Hills, CA, United States, 91301
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service